Hepatic cirrhosis causes pancytopenia: a case report


  • I. Made Bayu Surya Dana Department of Internal Medicine, Bob Bazar General Hospital, Kalianda, Lampung, Indonesia
  • Sherly Mediana Department of Internal Medicine, Bob Bazar General Hospital, Kalianda, Lampung, Indonesia
  • Wangsit Warsito Murti Department of Internal Medicine, Bob Bazar General Hospital, Kalianda, Lampung, Indonesia
  • Widodo Ariodhanu Department of Internal Medicine, Bob Bazar General Hospital, Kalianda, Lampung, Indonesia




Hepatic cirrhosis, Pancytopenia, Hypersplenism, Erythropoietin, Thrombopoietin, Chronic liver disease


Hepatic cirrhosis is a slow process liver disease, persisting over a long period of time, resulting in a progressive destruction, and is the final common pathological pathway. We report a case of 60-year-old man with hepatic cirrhosis and pancytopenia. He came to emergency room with chronic fatigue, light headed, and abdominal pain. In laboratory examination, hemoglobin 6.0 g/dL, red blood cell counts 2.8×106/mm3, platelets 58.000×103/mm3, leukocytes 3.800×103/mm3, and reactive HbsAg. Abdominal ultrasound revealed small liver with irregular edges, ascitic fluid, and enlarged spleen. The patient was treated with furosemide, spironolactone, lactulose and propranolol. The liver, or the hepatocyte constitutes a significant storage site for iron, produce erythropoietin and thrombopoietin. Hypersplenism causes retention of a large number of leukocytes, erythrocytes, and platelets in the spleen, and the number of retained blood cells can be 5.5-20 times higher than the normal level, thus facilitating capture, phagocytosis or destruction of blood cells by phagocytes resulting in peripheral cytopenias. This case illustrated that hepatic cirrhosis can cause pancytopenia. Therefore, we must look for any cause of pancytopenia in a patient with chronic liver disease. Lack of thrombopoietin and erythropoietin production, lack of iron storage in damaged hepatocyte, also splenic sequestration were the reason of pancytopenia in hepatic cirrhosis. Bone marrow examination is one of modalities that can be use, and still being recommended examination.


Marks PW. Hematologic Manifestations of Liver Disease. Seminars in Hematology. 2013;50(3):216-21.

Ashraf S, Naeem S. Frequency of Hypersplenism in Chronic Liver Disease Patients Presenting with Pancytopenia. Special Edition Annals. 2010;16(1).

Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014;20(23):7312-324.

Elsaid MI. The Burden Associated with Thrombocytopenia and Platelet Transfusions Among Patients with Chronic Liver Disease. Journal of Medical Economics 2020;23(4):378-85.

Yunfu Lv, et al. Causes of Peripheral Cytopenia in Hepatitic Cirrhosis And Portal Hypertensive Splenomegaly. Experimental Biology and Medicine. 2017;242:744-49.

Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and Its Complications: Evidence Based Treatment. World Journal Gastroenterology. 2014;20(18):5442-460.

Qamar AA, Grace ND. Abnormal Hematological Indices in Cirrhosis. Can Journal Gastroenterology. 2009;23(6):441-45.

Singh S. Association of liver cirrhosis severity with anemia: does it matter? Annals of Gastroenterology. 2020;33(3):1-5.

Gkamprela E. Iron Deficiency Anemia in Chronic Liver Disease: Etiopathogenesis, Diagnosis And Treatment. Annals of Gastroenterol. 2017;30:405-13.

Moore AH. Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options. Clinical Liver Disease. 2019;14(5):183-86.

Yunfu Lv, et al. Hypersplenism: History and Current Status (Review). Experimental and Therapeutic Medicine. 2016;12:2377-382.

Yokus O, Gedik H. Etiological causes of pancytopenia: A report of 137 cases. Avicenna Journal of Medicine. 2016;6:109-12.






Case Reports